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1. Introduction  
Late ventricular potentials (LVPs) are low amplitude, high frequency waveforms, appearing 
in the terminal part of the QRS complex of the electrocardiogram (Barbosa et al, 2002; Olinic 
& Zdrenghea, 1998), generated by diseased myocardium. They may extend in the ST 
segment (Zimmermann et al, 1983). Late ventricular potentials may be also defined as 
fragmented electrical activity, appearing in heterogeneous tissue areas, located at the border 
zone of a myocardial infarction (Fetsch, 1999). They are markers of an electrophysiological 
substrate for reentry ventricular tachycardia (VT) and sudden cardiac death (SCD) (Zipes et 
al, 2006).  
Most of the clinical research in this field is focused on risk stratification of patients with a 
history of myocardial infarction (MI), but the role of LVPs in other cardiac and extracardiac 
diseases is also discussed. At present, there is considerable interest on improved tests for 
risk stratification of sudden cardiac death and appropriate selection of prophylactic 
implantable cardioverter defibrillator recipients.   
2. History  
Late ventricular potentials were first reported by Berberi and Simson in dogs (Engel et al, 
2004). Berbari et al. (Berbari et al., 1978) first demonstrated that, using high-gain 
amplification, filtering and signal averaging, late potentials could be recorded. Initially, 
LVPs were obtained directly from the endocardium or epicardium, but they can be recorded 
from the body surface, as well. The amplitude of LVPs is too low to be detected on the 
standard surface ECG, requiring an amplified high-resolution ECG recording. Simson and 
Breithardt et al. first showed the clinical value of ventricular signal averaged 
electrocardiography (SAECG) for identification of patients with sustained VT (Breithardt et 
al., 1981; Simson, 1981).   
By the end of the 1980s, LVPs were helpful for the diagnosis, risk stratification and therapy 
of patients with ventricular arrhythmias. The initial enthusiasm diminished over time due to 
variability in the sensitivity, but lately, its predictive value for VT and fibrillation (VF) has 
been re-evaluated (Frances, 2010).  
SAECG was originally developed for use in patients with coronary artery disease and VT, 
but it has been subsequently applied to other groups of patients (Goldberger et al., 1994). 
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3. Recording of LVPs  
The amplitude of LVPs is in the order of microvolts and can not be detected on the standard 
surface ECG, requiring an amplified high-resolution ECG recording for their identification 
(Santangeli et al, 2008). Thus, LVPs are recorded using SAECG (Olinic & Zdrenghea, 1998).  
The leads are different from those used in standard 12-lead ECG. Most investigators use an 
XYZ lead system, made of three orthogonal bipolar electrode combinations (Engel et al, 
2004) and high-pass filtering. The leads are combined into a vector magnitude, a measure 
that sums up the high frequency information contained in all these leads. This vector 
magnitude is called filtered QRS complex (Santangeli et al, 2008). 
Considering the low intensity of LVPs, averaging of aproximately 300 ECG cycles is needed, 
in order to minimize the level of noise (Santangeli et al, 2008). The signal-to-noise ratio 
increases with the number of averaged beats (Gottfridsson et al, 2011). 
Recording of LVPs using body surface mapping is, also, possible (Linnenbank et al, 2001).  
3.1 Diagnosis criteria  
LVPs are present, if, according to an international convention (Goldberger et al, 2008), 2 of 
the following criteria (variables of the filtered QRS) (Fig. 1) are positive: 
 SAECG-QRS duration (SA-QRS)>120 ms. Other authors consider SA-QRS>114 ms 
(Breithardt et al, 1991; Lander et al, 1993) 
 LAS40: low amplitude signal (duration of the terminal part of the QRS complex with an 
amplitude below 40 μV) >38 ms 
 RMS40: root mean square signal amplitude of the last 40 ms of the signal < 20 μV. 
Each laboratory should define its own normal values (Breithardt et al, 1991). Other authors 
(Askenazi et al, 1978) use two sets of criteria to classify SAECG results. SAECG-I criteria are 
positive if one or more variables are abnormal, and SAECG-II criteria are positive if two or 
more variables are abnormal.   
 
 
Fig. 1. Late ventricular potentials in a patient with an old inferior myocardial infarction. 
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Besides temporal domain analysis, frequency domain analysis allows identification of 
arrhythmia risk considering changes of ECG frequency components. Frequency domain 
analysis was not validated in clinical practice. 
3.2 Limits  
The amplitude of the signals is low, and averaging the electrocardiogram, amplifying it and 
filtering out the low frequencies is needed (Mehta & Camm, 1989; Santangeli et al, 2008). 
Several noise sources may appear in highly amplified recordings: artifacts from respiratory 
muscles, electronic noise arising from the electrodes, electrical power lines and other nearby 
electronic equipment (Engel et al, 2004). Despite technical improvement of the devices, 
electrical interferences and preexistent electrophysiological changes may cause false negative 
results. High-pass filters may attenuate or abolish LVPs (Santangeli et al, 2008).   
Noise level was considered an important technical aspect influencing the results of the test. 
Steinberg and Bigger stated that the 0.3 μV level improves detection of late potentials 
(Steinberg & Bigger, 1989). The sensitivity of SAECG may be increased, by using a very low 
noise level (0.1 μV) (Frances, 2010). On the other hand, Engel et al. suggested that noise does 
not influence the SAECG variables and Christiansen et al. concluded that LVPs appear in 
healthy subjects at low noise levels (Christiansen et al, 1995; Engel et al, 1993). 
The weakness of LVPs is the low positive predictive value. However, their negative 
predictive value for arrhythmic events is very high (Santangeli et al, 2008).  
Difficulties may appear in detecting LVPs in patients with an anterior MI. Because of the 
early activation of the anterior regions during the normal sequence of electrical activation of 
the ventricles, delayed depolarization potentials of these regions after an anterior MI may 
not outlast the QRS complex, and therefore may be hidden within the QRS complex and not 
detected by SAECG (Santangeli et al, 2008).   
Patients with a prolonged QRS complex duration, due to a bundle-branch block (BBB) or 
intraventricular conduction defect, have late-occurring depolarization potentials caused by 
these conduction disorders (Galinier et al, 1996). Separate LVPs criteria were used for 
patients with BBB:   SA-QRS ≥145 ms, LAS40 ≥55 ms and RMS40≤17 μV (Galinier et al, 1996). 
Assessment of LVPs using multiple channel electrocardiographs, allows the use of the 
method in patients with wide QRS complexes, identifying the origin of LVPs . 
4. Predictive value of LVPs  
LVPs characterize ventricular depolarisation and its signal is more stable and easy 
reproducible compared to the repolarisation process (Askenazi et al, 1978).  
The positive predictive accuracy for malignant ventricular arrhythmias, in patients 
recovering from MI, of LVPs, ranges only from 8% to 29% (Santangeli et al, 2008). A high 
negative predictive value (90%) is mentioned for LVPs.  
5. Pathophysiology of LVPs 
LVPs represent delayed conduction through a diseased myocardium and indicate the 
presence of a potential anatomical substrate for macroreentry ventricular arrhythmias 
(Olinic & Zdrenghea 1998, Santangeli et al, 2008).    
LVPs appear as a consequence of late ventricular depolarisation due to delayed impulse 
conduction in certain myocardial regions (Olinic & Zdrenghea 1998; Engel et al, 2004). 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
230 
Decremental conduction appears in coronary heart disease due to decreased conduction 
speed in ischemic myocardium or due to a prolonged impulse propagation path (Breithardt 
et al, 1991).  
Certain conditions must be met by the area that provides LVPs. First, conduction must be 
slow enough to enable reentry in the healthy tissue. Second, a 1/1 conduction should be 
mentained at high frequencies; otherwise a bidirectional block appears and reentry is 
imposible. Third, an unidirectional block is needed, to allow depolarisation of the 
decremental zone in a single direction (Olinic & Zdrenghea, 1998).  
If the lenght of the reentry circuit is not long enough, the amplitude of the potentials can not 
be detected on the surface ECG and LVPs are absent despite arrhythmia favorable 
conditions. This explains the reduced positive predictive value of LVPs for ventricular 
arrhythmia (Olinic & Zdrenghea, 1998). 
In old MI, disorganised and asynchronous electrical activity arises from areas of surviving 
muscle at the border of a MI (Breithardt et. al, 1991; Savard et. al, 1997). Such areas are 
separated from each other by fibrous tissue, creating a disorganized, disconnected, 
heterogeneous network (Cain et al, 1996; Clayton, 2003).  Considering other opinions, LVPs 
arise in the viable cells inside the necrotic and fibrotic mass, or in the injured myocardial 
fibers, with slow conduction (Cain et al, 1996; La Vecchia et al, 1998; Turrini et al, 1999).  
An anatomical substrate, able to cause delayed conduction and produce LVPs, was reported 
in several other clinical conditions: dilated cardiomyopathy (Mancini et al, 1993), 
hypertrophic cardiomyopathy (Cripps et al, 1990), myocarditis, and infiltrative heart disease 
(Santangeli et al, 2008).   
LVPs are favored by modified tissue architecture due to: necrosis, fibrosis or dystrophy, 
causing a delayed and fragmented depolarization. Fibrosis disturbs ventricular activity, 
separates myocardial bundles and prolongs conduction pathways (Cain et al, 1996). 
Anisotropic reentry is the result of fibrosis in addition to the density and distribution of gap 
junctions, which are responsible for variations in the conduction velocity (Kitamura et al, 
2003; Peters et al, 1997). Some authors have demonstrated a close link between the 
distribution of the gap junctions, the specialized intercellular connections, and the 
development of reentrant arrhythmia in patients with healed MI and nonischemic dilated 
cardiomyopathy (Kitamura et al, 2003; Peters et al, 1997). The slow and discontinuous 
conduction caused by abnormalities in gap junction distribution and function form a 
functional, rather than anatomical, substrate for reentry (Santangeli et al, 2008).   
To generate an arrhythmia needs a substrate (LVPs), but also a trigger and maintenance 
(Santangeli et al, 2008).   
Arrhythmia triggers, such as acute ischemia, imbalance in autonomic tone, or the onset of 
clinical heart failure, may provide the link between the presence of LVPs and occurrence of 
spontaneous VT (Santangeli et al, 2008).   
When sympathetic tone to the heart is augmented, vagal activation exerts a protective effect 
on ventricular vulnerability. Sympathetic stimulation unopposed by vagal activity induces 
ventricular electrical instability, increases susceptibility to ventricular fibrillation, resulting 
in a high risk of arrhythmia and SCD (Gussak & Antzelevitch, 2008). Myocardial infarction 
may damage nerve pathways, thereby limiting the potential of the vagus nerve to be 
activated (Gussak & Antzelevitch, 2008). 
QRS prolongation may be explained by: intraventricular conduction disturbances and 
ventricular dilation, known to prolong ventricular conduction; and ventricular remodeling, 
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which increases tissue mass and slows conduction velocity. A correlation was found 
between QRS duration and end-diastolic volume after a few weeks after a MI. Some authors 
suggest that arrythmias are due to left ventricular dysfunction and do not depend on its 
etiology, considering that no differences were found in patients with myocardial ischemia or 
idiopathic cardiomyopathy (Kondo et al, 2001). 
Reentry explains the appearance of LVPs mainly in old myocardial infarctions, due to 
scarring. An abormal automatism due to a recurrent acute MI can also cause LVPs. A 
significant proportion of deaths occuring after discharge are caused by an arrythmia focus 
due to acute ischemia, hence the lack of sensitivity of LVPs in predicting SCD (Savard et al, 
1997). A prolonged QRS duration was suggested to be predictive for arrythmia SCD, 
regardless of arrythmia mechanism. 
LVPs extend beyond the normal QRS complex due to the low velocity, and may be detected 
in the ST segment, as well (Barbosa et al, 2002; Cain et al, 1996). Abnormal intra-QRS 
potentials, as markers of reentry, may also appear (Lander et al, 1993).  
6. Analysis of SAECG variables  
Positivity criteria for LVPs (SA-QRS, LAS40 and RMS40) are significantly influenced by 
several factors: age, gender and myocardial infarction location (Barbosa et al, 2002; Savard et 
al, 1997). Criteria adjusted for sex, age and myocardial infarction location were developed 
only for SA-QRS, due to its higher predictive value for arrhythmic events (Lander et al, 
1993).  
SA-QRS measured by SAECG is higher in men than in women. This can be attributed to the 
greater myocardial mass. The significant increase of SA-QRS in aging MI patients was 
attributed to degenerative processes afecting conduction (Mozos, 2007). 
All three SAECG variables showed significant predictive power for ventricular arryhthmic 
events. Several authors consider SA-QRS to have higher accuracy for arrhythmic events than 
any other combination of SAECG parameters (Ammann et al, 2004; Lander et al, 1993). 
Other authors concluded that RMS40 has the highest predictive value for ventricular 
arrhythmia (Nakai et al, 1988).  
In patients with inferior myocardial infarction and documented episodes of sustained VT, 
all variables were significantly different (lower voltages, longer durations) compared to 
patients with anterior infarction (Barbosa et al,  2002). LVPs can be better identified at higher 
frequencies, confirming the high frequency of these signals. 
7. The role of SAECG 
The predictive value of SAECG for arrhythmic events after a MI (Savard et al, 1997) exceeds 
that of other tests such as left ventricular ejection fraction (LVEF) or ambulatory ECG. The 
existence of LVPs increases 6 to 8 times the risk of arrhythmic events after a MI and it is 
considered the best non-invasive method to identify postinfarction VT risk (Ho et al, 1993). 
The widespread use of thrombolytic therapy, beta-blockers, antiplatelet therapy and 
revascularisation, lifetime changes and risk factor management, improved post-infarction 
survival. In this context and considering the proarrhythmic effects of antiarrhythmic drugs, 
it is important to identify patients with low risk. Due to its high negative predictive value, 
LVPs can play an important role in selecting patients for interventional studies. The role of 
SAECG as a screening test is limited due to the low positive predictive accuracy. 
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The behavior of LVPs on the body surface during programmed stimulation was evaluated 
by Ho et al (Ho et al, 1996), concluding that LVPs detected during sinus rhythm but lost 
after ventricular extrastimuli are often clinically irrelevant and may explain the false 
positive results and the reduced specificity of SAECG. LVPs revealed by ventricular 
extrastimuli but concealed during sinus rhythm may be clinically relevant and may explain 
some of the false negative results and the reduced sensitivity of SAECG.  
8. Myocardial infarction (MI) 
SAECG is still a very usefull method to identify MI patients at risk for lethal arrhythmic 
events (Huebner, 2010). In patients with acute MI, the electrophysiological substrate for 
LVPs gradually develop in the first 2 weeks of the acute event. LVPs were found in the first 
3 hours after MI onset and their prevalence increased in the next 7-10 days. LVPs recorded 
in the first week were associated with subsequent ventricular dilation and may be due to 
cell slides (Zaman et al, 1993).  
Once established, LVPs seem to remain indefinitely in most patients (Santangeli et al, 2008). 
LVPs can also disappear in the first year after an acute MI. Yang et al. consider that the 
prevalence of LVPs in the first week of a MI increases from 32% in the firs day to 52% in the 
days 7-10 (Yang et al, 1990).  
Time-dependend changes have been also attributed to cell death in the border zone of the 
MI or resolution of myocardial ischemia (Goldberger et al, 1994).  
In the second week and in old myocardial infarction, prevalence stabilizes at 25-35%. 
Savard et al. (Savard et al, 1997) consider that LVPs recorded after 5-15 days from an acute 
MI, are the best predictors of ventricular arrhythmia appearing in the first year. If LVPs are 
missing at hospital discharge, their subsequent appearance is unlikely (Kuchar et al, 1986). 
LVPs may disappear later due to reshuffle of the myocardial scar.  
In the first year after a transmural infarction, the predictive value of LVPs is low for SCD, 
because factors like: unidirectional block, heart rate and autonomic imbalance are triggering 
repetitive arrythmias. 
Patients with two MI (inferior and right ventricle) have a high prevalence of LVPs, 
independent of LVEF, and a high arrhythmia risk should be considered in those patients 
(Iltumur et al, 2001).  
Prevalence of LVP is 7-10% in coronary heart disease without myocardial infarction.  
Most studies on LVPs in MI patients were performed before the reperfusion era (Steinberg& 
Berbari, 1996). Studies investigating the effects of thrombolysis on LVPs reported 
controversial results. Bauer et al. (Bauer et al, 2005) suggested that LVP are of limited use for 
risk stratification in post infarction patients who received reperfusion/revascularization 
therapy. Zipes et al. considered that repermeabilisation of infarct related artery modifies the 
arrhythmogenic substrate and reduces the predictive power of LVPs (Zipes et al, 2006). The 
evidence for a benefit of thrombolysis on LVPs prevalence depended on the success of 
thrombolysis in achieving early and full coronary blood flow restoration (Hohnloser et al, 
1994). LVPs were found in 25% to 65% of patients with an occluded infarct-related artery 
despite thrombolysis, but in only 6% to 34% of those with a patent infarct-related artery 
after thrombolytic therapy (Chew et al, 1990). Malik et al. showed that the usefulness of 
LVPs to predict subsequent arrhythmic events was significantly worse in patients who 
received thrombolytic therapy than in those who did not receive thrombolytic therapy 
(Malik et al, 1992). The controversial results may be due to the differences in therapy, lack of 
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adequate randomization and controlled studies, different techniques of recording SA-ECG 
and criteria to define LVPs. Savard et al. demonstrated that the prevalence of arrhythmic 
events declined from 9.6% to 5.8% after trombolysis. Both the low positive predictive value 
(about 20%) and the high negative predictive value (97%) remained unchanged (Savard et 
al, 1997). 
Percutaneous coronary interventions (PCIs) are associated with a significant reduction of the 
prevalence of LVPs (Santangeli et al, 2008). Bauer et al. showed that LVPs were significantly 
associated with SCD (Bauer et al, 2005). Ikeda et al. reported no significant prognostic role of 
LVPs for SCD/resuscitated cardiac arrest at a short-term follow-up of 3 to 6 months, but 
LVPs were independent predictors of sustained VT (Ikeda et al, 2002). 
Reperfusion of severely ischemic myocardium may also lead to hemorrhages in the infarct 
core by extravasations of red blood cells through the damaged endothelium (Mather et al, 
2010). The presence of hemorrhage was associated with a prolonged SA-QRS in patients 
with first ST-elevation acute MI, treated successfully with PCIs.  
LVPs persist in patients not undergoing reperfusion, and may be caused by ventricular 
remodeling, involving fibrosis, redistribution of the fibers in the damaged region and one 
side left ventricular hypertrophy (LVH).  
9. Cardiomyopathies 
Cardiomyopathies are an important cause of SCD in young people.  
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC) is an inherited 
myocardial disease, characterized by fibro-fatty substitution of the right ventricle (Corrado 
& Thiene, 2006). The fibro-fatty areas can create reentry circuits, the substrate for repetitive 
ventricular arrhythmias and a delayed, fragmented activation font (Folino et al, 2006). The 
typical clinical manifestations are ventricular arrhythmias with left BBB pattern. LVPs were 
observed in more than 50% of patients with ARVC, and are minor diagnostic criteria in this 
setting (Santangeli et al, 2008). SAECG has shown particular reliability in ARVC, 
considering the classical location of the myocardial alterations in the right ventricle, which 
induce a delayed potential only in the terminal portion of QRS (Folino et al, 2006). Folino et 
al. (Folino et al, 2006) detected a progressive increase in delayed ventricular conduction, not 
associated with significant echocardiographic changes in patients with ARVC, and 
concluded that the baseline SAECG and echocardiographic parameters are useful in 
identifying patients with sustained VT. It was, also, hypothesized that the progression of the 
disease with an extension of fibro-fatty degeneration could completely isolate some 
infiltrated areas, with appearance of different preferential pathways of activation and 
reduction in late potentials (Folino et al, 2006).  
A close correlation was found between SAECG and extent of disease (Nava et al, 2000).  
Turrini et al, found an increased percentage of fibrous tissue and a high risk for sustained 
ventricular arrhythmias in patients with LVPs and ARVC (Turrini et al, 1999). The 
sensitivity of SAECG for diagnosis of ARVC increased by using only 1 of 3 criteria (Kamath 
et al, 2011).  
Santangeli et al (Santangeli et al, 2010) tested the association between noninvasive 
diagnostic criteria for ARVC and low voltage areas, detected at electroanatomic voltage 
mapping. SAECG abnormalities correlated with the presence of low voltage areas 
selectively in the right ventricular outflow tract, supporting the appropriateness of its 
inclusion among ARVC diagnostic criteria. 
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The prediction of sudden cardiac death is a major goal in the management of patients with 
hypertrophic cardiomyopathy (Cripps et al, 1990). Abnormal SAECGs were more prevalent 
in patients with hypertrophic cardiomyopathy compared to healthy controls, and were 
significantly associated with nonsustained VT on 48 h ECG Holter monitoring, but not with 
a family history of premature sudden cardiac death or a history of syncope (Cripps et al, 
1990).  
Fauchier et al. found a significantly higher incidence of severe ventricular premature beats 
in patients with idiopathic dilated cardiomyopathy (IDCM) and late ventricular potentials 
(Fauchier et al, 1991). Ohnishi et al. (Ohnishi et al, 1990 ) and Mancini et al. (Mancini et al, 
1993) mentioned a high incidence of prospective arrhythmias and SCD in patients with a 
IDCM and abnormal SAECG. Kitamura et al (Kitamura et al, 2003) concluded that the 
heterogeneous expression of connexin 43 protein may contribute to impaired ventricular 
conduction and LVPs detected on SAECG in patients with IDCM. Patchy interstitial fibrosis 
adjacent to viable myocardium is commonly seen in dilated cardiomyopathy. Fibrosis 
decreases electrical coupling, slows the propagation of impulses between myocytes and can 
become the anatomical substrate for reentrant VT. Alterations of the gap junctions are 
accompanied by discontinuity of tissue structure, which includes the naturally occurring 
myocardial cell orientation and the collagen matrix formed by the fibrosis (Kitamura et al, 
2003). The expression of connexin 43 was more decreased in patients with late ventricular 
potentials than in those without LVPs (Kitamura et al, 2003), but the degree of fibrosis seem 
not to influence the results. 
10. Congenital heart defects 
The predictive value of LVPs after repair of tetralogy of Fallot has been controversial. Al 
Balkhi et al. reported LVPs only 1 month after surgery in patients with tetralogy of Fallot, 
probably as a result of scarring (Al Balkhi et al, 2004). Zimmermann et al. found a 
correlation between inducibility of VT and LVPs (Zimmermann et al, 1991), but Giroud et al 
(Giroud et al, 1994) and Daliento et al. (Daliento et al, 1995) could not demonstrate a 
predictive value of LVPs alone in their studies. Janousek et al. found LVPs, and especially 
RMS40, to be predictive of spontaneous or induced VT in patients who underwent surgical 
correction of congenital cardiac disease (Janousek et al, 1995). 
11. Heart failure (HF) 
Patients with HF have a high SCD risk, despite therapeutic advances. Ventricular 
arrhythmias and SCD result from an interaction between a trigger and a substrate with 
neurohumoral factors (Bounhoure et al, 2010). The identification of the mechanisms of SCD 
in patients with HF is complicated by the different causes of HF. SCD risk correlates with 
the severity of congestive HF (Wilson et al, 1983). The high electrical instability in patients 
with post-infarction HF is due to structural inhomogeneities: patchy areas of fibrous tissue 
interdigitating with viable myocardium and scars. Interstitial fibrosis and hypertrophy are 
frequently seen on endomyocardial biopsies in patients with congestive HF. This can result 
in complex electrophysiological changes: abnormal impulse conduction with slow 
ventricular activation, changes in the refractory period responsible for ventricular 
arrhythmias (Bounhoure et al, 2010; Galinier et al, 1996).  
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There are conflicting results regarding the predictive value of LVPs for ventricular 
arrhythmias in HF patients. Small patient population studies (Meinertz et al, 1985; 
Middlekauff et al, 1990; Silverman et al, 1995) did not find SAECG to be predictive for SCD 
or ventricular arrhythmias in chronic HF. The studies by Mancini et al. and Galinier et al. 
found that the SAECG identified patients with congestive HF at high risk for death and/or 
ventricular tachycardia (Manicini et al, 1993; Galinier et al, 1996). 
According to current guidelines, most patients with left ventricular dysfunction and 
symptomatic HF may benefit from implanted devices and resynchronization therapy. It is 
important but difficult to identify patients at risk, and LVPs , combined with other 
electrocardiographic stratification methods, etiologic and clinical information, may help to 
select the candidates (Bounhoure et al, 2010). 
12. Brugada syndrome 
Brugada syndrome is characterized by abnormal repolarization in the right ventricle, 
detected as ST elevation in the right precordial leads, and depolarization abnormality, 
detected as right bundle branch block and LVPs (Morita et al, 2008). Repolarization 
heterogeneity within the epicardium of the right ventricular outflow tract seems to be the 
origin of reentry arrhythmia (Morita et al, 2007). A reduced sodium current, due to 
mutations of the sodium channel gene SCN5A, slows the conduction velocity and causes 
conduction abnormalities. Conduction abnormalities provide a substrate for the 
degeneration of polymorphic VT into VF (Meregalli et al, 2005).  
LVPs have been found in patients with the Brugada syndrome and might be helpful to 
identify patients at a higher risk of life-threatening arrhythmic events (Ikeda et al, 2001; 
Santangeli et al, 2008).  
Kutsuzawa et al. (Kutsuzawa et al, 2011) reported two patients with Brugada syndrome and 
hypokalemia induced lethal events. Normalization of serum potassium concealed the 
typical ECG pattern, but LVPs persisted even at 18-month follow-up. 
SAECG can detect not only LVPs, but also conduction abnormalities within the QRS 
complex: fragmented QRS (multiple spikes within the QRS complex) (Morita et al, 2008). It 
is considered that delayed activation within a small mass of ventricular tissue could 
produce LVPs and delayed activation in a larger ventricular mass can cause multiple spikes 
within the QRS complex. Fragmented QRS predicts syncope and VF in patients with 
Brugada syndrome (Morita et al, 2008). 
13. Syncope 
In patients with syncope of unknown cause, SAECG, combined with patient history and 
other diagnostic tests, can help identify or exclude a mechanism of VT as a cause of the 
syncope (Gang, et al, 1986; Santangeli et al, 2008).  
14. Atrial fibrillation and flutter 
It was hypothesized that the chaotic atrial activation in atrial fibrillation causes false-positive 
LVPs, making the analysis of SAECG very difficult (Buckingham et al, 1993; Halimi et al, 
1994). But, atrial fibrillation rarely creates problems with time-domain analysis of the 
SAECG (Fitzgerald et al, 1996; Halimi et al, 1994). LVPs analysis provides similar results in 
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atrial fibrillation and sinus rhythm, was concluded by Gottfridsson et al. (Gottfridsson et al, 
2011) in a study including 82 patients with atrial fibrillation, undergoing electrical 
cardioversion, despite decrease of heart rate and prolongation of SA-QRS. Conflicting 
results were obtained by different authors, analyzing SAECG variables after cardioversion. 
Halimi et al (Halimi et al, 1994) mentioned significant changes of LAS40 and RMS40 after 
cardioversion. Buckingham et al (Buckingham et al, 1993) found no significant changes of 
SA-ECG parameters. 
Atrial flutter waves occur during ventricular systole and mimic LVPs (Gatzoulis et al, 1993). 
In conclusion, atrial flutter can create significant errors in the automated time-domain 
analysis of the SAECG, and patients with atrial flutter should not undergo SAECG for 
postinfarction risk assessment (Fitzgerald et al, 1996).   
15. Bundle branch block (BBB) 
Increased QRS duration has been previously associated with increased mortality in patients 
with coronary heart disease and hypertensive patients (Brembilla-Perrot et al, 2001; Liew, 
2011). Syncope and dizziness may be related either to atrio-ventricular conduction 
disturbances or to ventricular arrhythmias. On the other hand, the presence of 
intraventricular conduction defects interferes with the detection of LVPs (Brembilla-Perrot 
et al, 2001; Englund et al, 1995), and, thus, patients with BBB are often excluded from the 
SAECG studies. Therefore, the management of these patients needs special attention.  
BBB decreased the specificity of the SAECG to predict VT risk in patients with dilated 
cardiomyopathy (Brembilla-Perrot et al, 1997). Among noninvasive parameters, only a 
prolonged SA-QRS (>165 ms) was a significant predictor of cardiac mortality (Brembilla-
Perrot et al, 2001). 
Delayed terminal conduction observed in incomplete right BBB may cause false positive 
LVPs (Manolis et al, 1997). In order to prevent false positive results, separate LVPs criteria 
were used for patients with BBB (Galinier et al, 1996). 
16. Hypertension (HT) 
A significant association has been demonstrated between hypertension and SCD (Yildirir et 
al, 2002). The risk of SCD due to ventricular arrhythmias was demonstrated by a prolonged 
QT interval or LVPs. The most important mechanisms by which HT predisposes to SCD are: 
the degree of left ventricular hypertrophy (LVH), interstitial fibrosis, myocardial or 
subendocardial scars, silent myocardial ischemia, diastolic dysfunction and disturbances in 
cardiac autonomic balance (Galinier et al, 1997; Kaftan AH & Kaftan O, 2000; Palatini et al, 
1995; Yildirir et al, 2002). Coronary artery disease may interact with LVH in the genesis of 
ventricular arrhythmias and SCD (Galinier et al, 1997). 
LVPs wer found by several authors in HT (Brune et al, 1991; Vester et al, 1992). Galinier et 
al. (Galinier et al, 1992) and Franchi et al. (Franchi et al, 1992) found a greater prevalence of 
LVPs in subjects with eccentric LVH than in those with concentric hypertrophy. Non-
sustained VT has been found to have a prognostic value in HT patients (Galinier et al, 1997). 
Vardas et al. (Vardas et al, 1994) and Palatini et al (Palatini et al, 1995) confirmed that a high 
prevalence of ventricular arrhythmias was associated with LVPs in HT patients. Only the 
E/A ratios were related to the presence of either LVPs or VT, and they were far lower in 
patients with LVPs (Palatini et al, 1995).  
www.intechopen.com
 
Late Ventricular Potentials in Cardiac and Extracardiac Diseases 
 
237 
The initial reports of the Framingham Heart Study demonstrated the deleterious effect on 
survival of LVH (Kannel & Abbot, 1986; Levy et al, 1990). A downward trend in the 
prevalence of LVH was noticed in the last decades, which coincided with improved HT  
control (Priori et al, 2001). A lack of a relation between left ventricular mass and the 
occurrence of LVPs has been also reported by some authors (Panagides et al, 1990; Prisant et 
al, 1993; Rizzo et al, 2000). 
Experimentally, LVH delays ventricular conduction and prolongs action potential duration. 
Electrocardiographic QRS duration and QT interval measures reflect these changes 
(Oikarinen et al, 2004). The increased QRS duration may be attributed to the increased 
thickness of the left ventricle wall and to intramural fibrosis, which distorts and prolongs 
transmural impulse propagation, or it could be a manifestation of intraventricular or 
interventricular conduction delay or block (Hancock et al, 2009). Alterations in ion channels 
due to hypertrophy were also mentioned as possible causes of QT interval prolongation in 
LVH (Hancock et al, 2009).  
LVPs were present in both dippers and nondippers, and the values were significantly lower 
in dippers for SA-QRS and LAS40, and nondipper pattern was not linked to a worse 
arrhythmogenic substrate (Rizzo et al, 2000).  
There is no study with power to show prognostic significance of LVPs in HT patients. All 
studies on LVPs in hypertensive patients have all been small scale, with short follow up.  
17. Dyslipidemia and metabolic syndrome 
The epidemiological association between elevated LDL cholesterol and risk of all 
manifestations of coronary artery disease including SCD is well established (Priori et al, 
2001). A relation between dyslipidemia and electrical instability has been hypothesized. 
Gimaev et al. (Gimaev et al, 2009) evaluated the effect of disturbed lipid metabolism on 
SAECG characteristics and found LVPs in patients with high, moderately elevated, low and 
normal serum cholesterol. Hypercholesterolemia has been reported to induce proarrhythmic 
sympathetic neural sprouting and ventricular electrophysiologic remodeling, and an 
increased vulnerability to VF in a high-fat-fed animal model (Liu et al, 2003). 
A significant correlation was found between serum cholesterol and SAQRS, LAS40 and 
RMS40 in patients with an old MI (Mozos & Hancu, 2010). 
Clinical trials of lipid lowering in the primary prevention of coronary artery disease have 
not evaluated SCD risk, and have not sufficient statistical power to identify a significant 
reduction (Priori et al, 2001).  Statins seem to have antiarrhythmic properties in addition to 
their lipid-lowering effects (Chu et al 2007; Abuissa et al, 2009). 
Isolated metabolic syndrome is associated with an increase in left ventricular mass index 
and diastolic dysfunction, increasing the risk of cardiovascular disease (Aijaz et al, 2008). 
The prevalence of increased QT interval duration has been investigated with respect to 
single components of the metabolic syndrome (Strohmer et al, 2007).  
18. Obesity 
Patients with morbid obesity have high rates of sudden, unexpected cardiac death (Duflou 
et al, 1995). An increased prevalence of abnormal SAECG results has been found in obese 
patients without known clinical heart disease, and body mass index (BMI) can be considered 
as an independent predictor of abnormal SAECG results (Lalani et al, 2000). Mizia-Stec et al . 
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(Mizia-Stec et al, 2000) found an increased QT dispersion (QTd) in obese women, associated 
with LVH and significantly higher QTd in patients with late ventricular potentials. 
The mechanism of death in these patients remains uncertain. Parasympathetic withdrawal, 
occuring with increasing obesity, conduction abnormalities, cardiomyopathy of obesity, the 
lipotoxicity of the myocardium induced by free fatty acids, released from hypertrophied 
adipocytes in obese persons with myocardial steatosis, structural heterogeneity due to fatty 
infiltration of the heart, myocyte hypertrophy, focal myocardial disarray, fibrosis and 
mononuclear cell infiltration could be involved (Alexander, 1985; Bharati & Lev, 1995; 
Duflou et al, 1995; Lalani et al, 2000). Particularly, with a concentric pattern of LVH, the 
prevalence of ventricular ectopic beats is substantially elevated in obese patients (Schunkert, 
2002). The cardiomyopathy of morbid obesity, the most common cause of SCD in these 
patients, is characterized by cardiomegaly, left ventricular dilatation, and myocyte 
hypertrophy in the absence of interstitial fibrosis.  
A BMI associated increase in chronic MI patients’ SCD risk was mentioned by Mozos et al. 
and SAECG-QRS and LAS40 correlated with BMI in patients with an old MI (Mozos et al, 
2007).  
19. Diabetes mellitus and hyperglycemia 
There is controversy in the literature as to whether glucose intolerance or diabetes mellitus 
are independent risk factors for SCD (Priori et al, 2001). Streptozocin experimentally 
induced diabetes impairs both depolarization and repolarization (Pacher et al, 1999). QT 
interval prolongation in diabetic patients has been attributed to autonomic neuropathy and 
insulin resistance, and in healthy non-diabetic subjects with high plasma glucose, to 
increased cytosolic calcium content, oxidative stress and enhanced sympathetic activity 
(Muntean et al, 2009).  
Kowalewski et al. (Kowalewski et al, 2002) included 72 children with type 1 diabetes 
mellitus in his study and found an increased prevalence of abnormal SAECGs and LVPs. 
Diabetic children with LVPs had thicker left ventricular posterior wall and longer diabetes 
duration time than children without LVPs. Nonlinear regression model showed that 
duration of diabetes, cardiac autonomic neuropathy, and left ventricular posterior wall were 
the strongest independent parameters of LVPs occurrence. 
An association between hyperglycemia on admission in patients with acute ST elevation MI 
and arrhythmias during hospitalization has been observed (Sanjuan et al, 2011). Stress 
hyperglycemia on admission was found to be a predictor of mortality and arrhythmias in 
patients with acute ST elevation MI and could be used in the stratification of risk in these 
patients (Pinto et al, 2008; Sanjuan et al, 2011).  
20. End-stage renal failure and hemodialysis 
Cardiac disease is the major cause of death in dialysis patients (Herzog et al, 2008). LVH 
with interstitial fibrosis, deposition of calcium and aluminum salts in the heart tissue often 
occur in patients with end-stage renal disease (ESRD) (Morales et al, 1998). Autonomic 
neuropathy and impairment of left ventricular functions have been frequently encountered 
in chronic renal failure and depend on the disease duration (Karayaylali et al, 2003). SCD 
risk due to ventricular arrhythmias is high in ESRD patients on hemodialysis (HD) 
(Dubrava et al, 2003; Sakhuja et al, 2009). SAECG parameters are abnormal in a significant 
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proportion of patients with chronic renal failure (Girgis et al, 1999). The mentioned 
histological changes could represent a potential substrate for LVPs. LVH was already 
considered as SA-QRS prolonging factor in hypertensive patients (Vester et al, 1992) and 
associated with a high prevalence of LVPs in post-infarction HF patients (Mozos et al, 2009). 
This explanation appears unlikely in renal failure. Morales et al. did not detect significant 
differences in left ventricular mass between end-stage renal failure patients with and 
without late ventricular potentials before HD (Morales et al, 1998). Roithinger et al. did not 
find a significant association between mortality and LVPs or structural myocardial changes 
in HD patients, but a tendency towards an excess mortality of patients with coronary artery 
disease and compromised left ventricular function (Roithinger et al, 1992). On the other 
hand, Girgis et al. concluded that SAECG parameters improve with HD, and, decreased left 
ventricular dimensions, because of fluid removal during HD, (Girgis et al, 1999).  
Volume, electrolyte, acid-base balance, heart rate and blood pressure changes appearing 
during HD, can trigger supraventricular and ventricular arrhythmias (Dubrava et al, 2003; 
Morales et al, 1998). Most of the studies performed in HD patients have focused on QRS 
amplitude and T wave (Morales et al, 1998). Abnormalities in SAECG were also mentioned 
in patients undergoing HD and peritoneal dialysis (Girgis et al, 1999; Ichikawa et al, 1997; 
Morales et al, 1998; Roithinger et al, 1992).  
The prevalence of late ventricular potentials was 25% in the study of Morales et. al (Morales 
et al, 1998), including patients with a known history of myocardial infarction, and only 14% 
in another study including younger patients, with a lower prevalence of coronary heart 
disease (Roithinger et al, 1992). Ichikawa et al reported no LVPs before HD and abnormal 
SAECGs in only 2.4% of the patients (Ichikawa et al, 1997). Late ventricular potentials were 
attributed to underlying coronary heart disease with left ventricular dysfunction (Morales et 
al, 1998). Most of the studies reported improved SAECGs after HD. 
Morales et al and Ichikawa et al reported a prolongation of SA-QRS duration after dialysis 
(Ichikawa et al, 1997; Morales et al, 1998), probably due to widening of the initial portion of 
the QRS, related to the acute reduction in serum potassium (Morales et al, 1998). Girgis et al. 
showed that only LAS40 and RMS40 change significantly after hemodialysis (Girgis et al, 
1999). LAS40 was also significantly increased postdialysis in a study of Ichikawa et al, and 
the changes in LAS40 correlated with the changes in potassium in the high-K group 
(Ichikawa et al, 1997). Larger studies are needed to verify the effect of HD on time-domain 
SAECG parameters.  
Animal studies demonstrated that hypokalemia-induced arrhythmogenicity is due to 
slowed conduction, prolonged ventricular repolarisation (caused by inhibition of outward 
potassium currents) and abnormal pacemaker activity (Osadchii, 2010). Hypokalemia effect 
on repolarisation is not uniform, causing amplified spatial repolarisation gradients and an 
unidirectional conduction block (Osadchii, 2010). Prolongation of action potential may be 
associated with shortening of the effective refractory period, facilitating reentry. Serum 
potassium between 4.6 and 5.3 mEq/l was associated with best survival in HD patients, and 
potassium <4 or ≥5.6 mEq/l was associated with increased mortality (Kovesdy et al, 2007). 
An insufficient decrease of serum potassium by hemodialysis was suggested to be an 
arrhythmogenic factor (Ichikawa et al, 1997). 
21. Alcoholism 
Acute alcoholic states, binge drinking, the “holiday heart syndrome” and liver cirrhosis are 
associated with prolonged QT intervals and an increased prevalence of cardiac arrhythmias 
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and SCD (Day et al, 1993; Genovesi et al, 2008; Wever & Robles de Medina, 2004;). In 
contrast, case-control studies have demonstrated a protective effect of moderate alcohol 
consumption against sudden cardiac death (Priori et al, 2001; Vreede-Swagemakers et al, 
1999). Alcohol inhibits the Na-K-ATPase, which alters the resting membrane potential, 
delays calcium binding and transport by the cardiac sarcoplasmic reticulum and impairs 
calcium channels (Lorsheyd & de Lange, 2005). 
Life-threatening ventricular arrhythmias are found in alcoholics without heart disease 
(Moushmoush et al, 1991). Alcoholic cardiomyopathy is associated with localized delays in 
intraventricular conduction and nonuniform myocardial involvement (Luca, 1979). 
Koskinen & Kupari did not find LVPs in chronic alcoholics without detectable heart disease 
(Koskinen & Kupari, 1993). The absence of LVPs does not exclude nonuniformity of alcohol 
induced myocardial changes.  
Chronic heavy alcohol consumption increases left ventricular mass and may cause 
subclinical impairment in left ventricular function (Luca, 1979).    
Pochmalicki et al. found LVPs in chronic alcoholics (Pochmalicki et al, 1997) and concluded 
that cronic alcohol intake, sufficient to cause histologically significant fatty liver, is ssociated 
with LVPs. LVPs could reveal early, preclinical myocardial lesions, and help to identify 
alcoholic patients at high risk of lethal arrhythmias. 
22. Chronic obstructive pulmonary disease (COPD) 
COPD is an independent risk factor for cardiovascular morbidity and mortality (Celli et al, 
2010). Potential explanations for this association include: smoking, negative cardiac 
consequences of dynamic hyperinflation, exercise limitations and hypoxemia (Celli et al, 
2010; Priori et al, 2001). 
Carjea (Carjea, 2003) studied the prevalence and characteristics of late ventricular potentials 
in 90 patients with COPD compared to healthy subjects and found significant differences. 
The highest prevalence was noticed in moderate to severe cases. 
23. Acromegaly 
The heart is an end-organ of growth hormone action. A high prevalence of complex 
ventricular arrhythmias has been mentioned in patients with acromegaly, possible as a 
result of disordered left ventricular architecture and ventricular remodeling (Clayton, 
2003).  
The frequency of premature ventricular complexes increased with duration of acromegaly, 
and the severity of arrhythmia correlated with left ventricular mass but not with growth 
hormone levels (Kahaly et al, 1992). Structural heterogeneity in acromegalic heart is due to 
areas of hypertrophied myocytes, separated by fibrosis and cellular infiltrations (Clayton, 
2003). Late ventricular potentials are frequently seen in active acromegaly, are associated 
with disease activity and may represent an early and sensitive parameter to detect 
myocardial injury (Herrmann et al, 2001). No association was found between presence of 
late ventricular potentials and left ventricular mass index. Longitudinal studies are needed 
to determine whether therapy changes the electrophysiological abnormalities.  
Earlier studies showed that arrhythmias were as frequent before and after treatment of 
acromegaly, implying that fibrous tissue infiltration caused irreversible scarring (Hayward 
et al, 1987; Rodrigues et al, 1989). 
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Beta–thalassemia, the impaired production of the beta hemoglobin chain, is associated with 
significant changes in heterogeneity of cardiac ventricular repolarization and SCD (Russo et 
al, 2011). In the late stages, frequent premature ventricular contractions and sustained 
ventricular tachycardia have been mentioned, related to cardiac death. Thalassemia patients 
require intensive blood transfusions due to severe anemia, and an increase in body iron 
burden occurs both in patients who are or are not receiving transfusions (Lekawanvijit & 
Chattipakorn, 2009). 
The role of iron overload in causing conduction delays in the thalassemic heart is well 
documented and iron overload thalassemic cardiomyopathy may explain the occurrence of 
LVPs (Isma'eel et al, 2007), as well as changes in QRS duration and RMS40 voltage. The 
patchy nature of cardiac iron deposition may provide substrates for re-entry and risk of fatal 
arrhythmias (Lekawanvijit & Chattipakorn, 2009). Iron-overloaded cardiomyocytes have a 
smaller overshoot potential and shorter action potential duration than iron-free 
cardiomyocytes in the same heart and reduced Na+ currents may be an underlying 
mechanism (Lekawanvijit & Chattipakorn, 2009). Further mechanisms related to 
tachyarrhythmias and SCD are changes in calcium homeostasis, elevated prostaglandin E2 
to prostacyclin ratio, increased interleukin 1 level and lipid peroxidation. 
Future large populations, long-term follow-up studies are needed to demonstrate further 
clinical consequences in iron overload cardiomyopathy. 
25. Connective tissue and systemic diseases 
Cardiovascular involvement is common in connective tissue diseases (Lazzerini et al, 2006), 
but myocardial involvement is seldom recognized clinically (Stanescu & Dan, 1992). 
Ventricular arrhythmias represent a major cause of SCD in autoimmune rheumatic diseases 
(Sefarovic et al, 2006). The mechanisms are probably multiple and myocardial fibrosis seems 
to play a pivotal role (Lazzerini et al, 2006). Lazzerini et al (Lazzerini et al, 2007) concluded 
that anti-Ro/SSA positive patients have a particularly high risk of developing ventricular 
arrhythmias.  
The heart is one of the major organs involved in scleroderma. Ventricular arrhythmias are 
common among asymptomatic patients with systemic sclerosis, especially: premature 
ventricular contractions and non-sustained VT (Sefarovic et al, 2006). Patchy myocardial 
fibrosis represents an ideal substrate for reentry tachyarrhythmias. LVPs occurred in 
patients with diffuse progressive systemic sclerosis; a lower myocardial involvement was 
noticed in the CREST syndrome (Paradiso et al, 1996). Diffuse abnormalities of the cardiac 
tissue detected by SAECG may be present in patients with systemic sclerosis without 
cardiac symptoms and higher skin scores correlated with the presence of LVPs (Paradiso et 
al, 2002). Pignone et al (Pignone et al, 1994) found no correlation between LVPs and 
immunologic patterns, cutaneous and pulmonary involvement in 26 patients with systemic 
sclerosis. 
Myocardial lesions in systemic lupus erythematosus are characterized by an increase in 
interstitial connective tissue and myocardial scarring (Paradiso et al, 2001).  The most 
important cardiac manifestations of systemic lupus erythematosus are: pericarditis, lesions 
of valves, myocardium and coronary artery disease (Gomez-Leon Manduiano & Amezcua-
Guerra, 2008). Sinus and atrial arrhythmias are more prevalent, but QT interval 
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prolongation, abnormalities in the autonomic tone and LVPs indicate high risk of 
developing life-threatening ventricular arrhythmias (Sefarovic et al, 2006). LVPs were 
recorded in patients with systemic lupus (Paradiso et al, 2001; Wranicz et al, 2001), and the 
depolarization abnormalities revealed by SAECG reflect a longer extent of myocardial 
fibrosis and echocardiography and SAECG alterations are markers of subclinical myocardial 
involvement. Increasing evidence suggest that anti-Ro/SSA antibodies may trigger rhythm 
disturbances due to an inhibiting cross-reaction with several cardiac calcium and potassium 
ionic channels (Lazzerini et al, 2010).  
So far, the evidence related to electrocardiographic disturbances in this setting is restricted 
to studies with small number of patients (Teixeira, et al, 2010). The mechanisms of 
arrhythmias are related to the inflammatory process of pericarditis and myocarditis, 
atherosclerotic myocardial ischemia, increased sympathetic activity, vasculitis of small 
vessels with collagen deposits and anti-Ro/SSA antibodies (Lazzerini et al, 2010; Teixeira, et 
al, 2010). 
Cardiac sarcoidosis affects the myocardium, pericardium and endocardium, and the disease 
may present with: atrioventricular and intraventricular conduction disturbances, ventricular 
arrhythmias and HF. Ventricular arrhythmias are among the main causes of SCD in cardiac 
sarcoidosis. LVPs on SAECG were mentioned and they were abolished after steroid therapy 
(Yodogawa et al, 2011). 
26. Schizophrenia 
Schizophrenia patients were also found to be positive for LVPs. Cardiac autonomic 
dysregulation in schizophrenia patients and use of psychiatric and/or non-psychiatric 
medications that affect conduction, may account for LVPs (Nashoni et al, 2010). 
27. Influence of therapy on LVPs 
LVPs are influenced by antiarrhythmic therapy, trombolytic drugs, anevrismectomy, 
percutaneous coronary interventions, coronary artery bypass surgery, statins, steroids. 
The effect on the prevalence of LVPs of modern pharmacologic therapy in patients with 
acute MI has been assessed in several studies (Santangeli et al, 2008). Class I, II and III 
antiarrhythmics may reduce the prevalence of LVPs.  Class IV antiarrhythmics (Verapamil) 
do not influence LVPs. Some class III antiarrhythmic drugs are able to prolong SA-QRS and 
LAS40, and may be associated with the occurence of LVPs.  
Freedman and Steinberg showed that sodium channel blockers (quinidine, procainamide, 
imipramide) have preferential effects on slowly conducting tissue in patients with a history 
of VT, causing an important prolongation of LVPs (Freedman & Steinberg, 1991).  
Santarelli et al, reported that LVPs were less frequent in acute MI patients treated with 
betablockers compared with those not treated with betablockers during hospitalization. This 
effect was found only in patients with a preserved LVEF (Santarelli et al, 1993).  
No significant SAECG changes have been observed after Sotalol. 
Adrenergic stimulation with adrenaline and isoprenaline, and parasympatholytic agents 
such as atropine, lead to significant changes in the signal averaged electrocardiogram in 
healthy subjects (Goldberger et al, 1994). Beta-adrenergic stimulation with isoproterenol led 
to a significant shortening of SA-QRS, and epinephrine prolonged the QRS duration. 
Increased alfa-adrenergic stimulation with phenylephrine and parasympathetic stimulation 
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did not affect the SAECG. Parasympathetic blockade caused a mild decrease in the QRS 
duration. Changes in the RMS40 and LAS40 paralleled those of the QRS duration 
(Goldberger et al, 1994). 
Junker et al, found in a substudy of the CONSENSUS II trial, a reduced prevalence of LVPs 
after the angiotensin converting enzyme inhibitor enalapril (Junker et al, 1995). 
Lipid-lowering interventions reduce coronary events, VT/VF episodes, SCD and all-cause 
mortality (Liu et al, 2009). Recent studies have demonstrated that statins have 
antiarrhythmic properties in addition to their lipid-lowering effects (Abuissa et al, 2009; Chu 
et al 2007; Liu et al, 2009).  Kayikcioglu et al. found a significant decrease of the prevalence 
of LVPs and ventricular arrhythmias in acute MI patients receiving pravastatin, irrespective 
of lipid level (Kayikcioglu et al, 2003). Pre-treatment with statin could reduce the 
reperfusion arrhythmias after acute myocardial infarction (Zhao et al, 2008). Most of the 
antiarrhythmic benefits after statin therapy observed in high cardiovascular risk patients 
might be explained by statins’ pleiotropic effects: anti-ischemia, anti-inflammation, 
antihypertrophy, angiogenic and sympathetic effects (Chu et al, 2007). Statins achieve their 
antiarrhythmic drug action in part by preventing or reversing electrophysiologic 
remodeling induced by hypercholesterolemia, but they also have an independent 
antiarrhythmic effect (Liu et al, 2009).  
The ratio between QTc and QRS changes caused by several antiarrhythmic drugs identifies 
patients with sustained VT risk, which appear despite therapy (Cain et al, 1996). 
LVPs may disappear after coronary artery bypass surgery in acute MI patients (Bigger et al, 
1997). Anevrisectomy is also known to reduce the prevalence of LVPs.   
Corticosteroid therapy may be effective for ventricular arrhythmias in the early stage of 
cardiac sarcoidosis (Yodogawa et al, 2011). 
28. Correlation and combination with other ECG methods 
Several studies have mentioned correlations between surface standard 12-lead ECG and 
SAECG parameters. The relation between LVP and QT dispersion (QTd) (Ducceschi et al, 
1996; Mozos, 2006), suggested that the existence of some slow conducting myocardial areas, 
related to positive LVPs, is associated with a higher inhomogeneity of ventricular 
repolarisation, expressed as a higher QTd. LAS40 and SA-QRS correlated with QT 
dispersion (Ducceschi et al, 1998).  
QT intervals and Tpeak-Tend intervals were prolonged in post-infarction HF patients with 
LVPs. LVPs and SAECG parameters can be predicted using 12-lead ECG: QT intervals, QRS 
duration, T wave variables (Mozos et al, 2011). The significant association between SA-QRS 
and Tpeak-Tend interval and T wave amplitude was attributed to the extension of LVP into 
the ST segment.   
Breithardt et al. (Breithardt et al, 1990) showed that the presence of LVPs was positively 
correlated with an ECG score based on R and Q wave duration and R/S ratio in MI patients 
with or without a history of sustained VT.  
LVPs were not related to the frequency of ventricular ectopic activity and malignant 
premature ventricular contractions because each test assesses different components of 
arrhythmia susceptibility. The combination of the two abnormalities may identify a high-
risk group for SCD (Middelkauff et al, 1990; Fauchier et al, 1991).  
The combination of T wave alternans and SAECG, increases sensitivity, specificity, positive 
and negative predictive value for VT risk (Kondo et al, 2001).   
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SAECG and body surface mapping (BSM) provide complementary information in patients 
with an old MI, and an important, significant correlation was found between isointegral 
QRST maximum and LAS40 and RMS40 (Mozos et al, 2008). SAECG may be assessed using 
BSM, increasing its sensitivity in anterior and inferior MI (Ho, 1993). BSM may detect LVPs, 
undetected by SAECG, even if the underlying substrate is relative small or the electrodes are 
placed outside that area (Linnenbank et al, 2001). Analysis of isopotential maps of the 
terminal part of the QRS complex may provide additional information regarding LVPs 
distribution, slow conducting areas and VT origin (Faugere et al, 1986). 
29. LVPs and other ventricular arrhythmia predictors 
Despite the significant predictive value for arrhythmic events, LVPs show a low positive 
predictive accuracy, thus resulting in limited usefulness as a single variable to identify 
patients at high risk (Santangeli et al, 2008). Significantly impaired LVEF is an established 
predictor of SCD and is included in the current guidelines for primary prevention of SCD. 
But patients with a preserved LVEF are not included in the current guidelines (Liew, 
2011). 
Combination of LVPs with LVEF (Jain & Avasthi, 1992; Konta et al, Kudaiberdieva et al, 
2003), ventricular volumes (Pollak et al, 1985), heart rate variability (Gomes et al, 2001), 
ventricular diskinezia (Olinic & Zdrenghea, 1998), programmed ventricular stimulation 
(Ho et al, 1996), atrial pacing (Steinbigler et al, 1999), a high Killip class (3 or 4) in a 
patient with a history of a MI, may improve the predictive value of LVPs for ventricular 
arrhythmias.  
Kudaiberdieva et al (Kudaiberdieva et al, 2003) investigated incidence of ventricular 
tachycardia/ventricular fibrillation in relation with noninvasive arrhythmia risk markers in 
54 patients with an old myocardial infarction. Logistic regression analysis revealed that the 
highest association with ventricular tachyarrhythmia had combination of LVPs and 
increased QT variability index, followed by combination of LVPs and left ventricular 
ejection fraction. 
Standard methods fail to reveal late potentials in 20 to 30% of patients with ventricular 
arrhythmias after myocardial infarction (Steinbigler et al, 1999). Increase in heart rate may 
unmask late potentials in patients prone to malignant ventricular arrhythmias, because 
conduction in the arrhythmogenic area is critically slowed by an increased heart rate. 
Functional late potential analysis, with non-invasive clinical stress tests, should be 
performed in order to identify patients at risk of malignant ventricular arrhythmias, not 
identified with conventional late potential analysis (Steinbigler et al, 1999). 
Epicardial mapping has demonstrated that during sinus rhythm, activation of the tissue 
critical to ventricular tachycardia is completed before the end of the QRS complex and is not 
detectable within the ST segment (Steinbigler et al, 1999). A shift of septal mid-QRS 
potentials toward the terminal QRS complex by critical slowing of conduction during 
increased heart rate, could explain the appearance of new late ventricular potentials. 
Different findings may be due to myocardial infarction location: an increase of QRS duration 
in patients with anterior infarction and an increase of magnitude and LAS40 in patients after 
inferior infarctions (Steinbigler et al, 1999). 
Combining electrocardiography methods with other methods may help to select the 
candidates for pharmacological therapy, defibrillator implantation and resynchronization, 
in order to reduce overall mortality and SCD. 
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Sudden cardiac death, caused mainly by fatal ventricular arrhythmias, can be predicted 
using a practical and low-cost tool: SAECG. LVPs represent slowed conduction through a 
diseased myocardium and may form the substrate for life-threatening ventricular 
arrhythmias in patients with cardiac and extracardiac pathology. SAECG is altered due to a 
variety of physiological and pharmacologic conditions. Antiarrhythmic therapy, trombolytic 
drugs, anevrismectomy, percutaneous coronary interventions, coronary artery bypass 
surgery, statins and steroid therapy are able to influence LVPs. Late ventricular potentials 
have a high negative predictive value. When positive, LVPs help better stratify the 
arrhythmic risk of patients, alone or in combination with other methods, in several clinical 
settings.  
31. References  
Abuissa H, O’Keefe JH, Bybee KA. (2009). Statins as anti-arrhythmics: a systematic review 
part II: effects on risk of ventricular arrhythmias. Clin Cardiol, 23(10), pp. 542-52 
Aijaz B, Ammar KA, Lopez-Jimenez F, et al. (2008). Abnormal cardiac structure and function 
in the metabolic syndrome: a population-based study. Mayo Clin Proc, 83(12), pp. 
1350-7  
Al Balkhi R, Beghetti M, Friedly B. (2004). Time course of appearance of markers of 
arrhythmia in patients with tetralogy of Fallot before and after surgery. Cardiol 
Young, 14, pp. 360–366 
Alexander JK. (1985). The cardiomyopathy of obesity. Prog Cardiovasc Dis, 28, pp. 325-34 
Ammann P, Bluzaite I, Roelli H, et al. (2004). Correlation of QT dispersion after Exercise 
Stress-Test with Coronary Artery Disease. Elektronika ir Elektrotechnika,  2(51), pp. 
78-81 
Askenazi J, Parisi AF, Cohn PF, et al. (1978). Value of the QRS complex in assessing left 
ventricular ejection fraction. Am J Cardiol, 41(3), pp. 494-499 
Barbosa Benchimol PR, de Sousa MO, Correa Barbosa E, et al. (2002). Analysis of the 
Prevalence of Ventricular Late Potentials in the Late Phase of Myocardial Infarction 
Based on the Site of Infarction. Arq Bras Cardiol, 78, pp. 358-63 
Bauer A, Guzik P, Barthel P, et al. (2005). Reduced prognostic power of ventricular late 
potentials in post-infarction patients of the reperfusion era. Eur Heart J, 26, pp. 755–
761 
Berbari EJ, Scherlag BJ, Hope RR, et al. (1978). Recording from the body surface of 
arrhythmogenic ventricular activity during the S-T segment. Am J Cardiol, 41, pp 
697– 702 
Bigger Jr JT. (1997). Prophylactic use of implanted cardiac defibrillators in patients at high 
risk for ventricular arrhythmias after coronary-artery bypass graft surgery. 
Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med, 337, 
pp. 1569 
Bharati S & Lev M. (1995). Cardiac conduction system involvement in sudden death of obese 
young people. Am Heart J, 129, pp. 273-81 
Bounhoure JP, Galinier M, Boveda S, et al. (2010). Ventricular arrhythmias, sudden death 
and heart failure. Bull Acad Nat Med, 194(6), pp. 997-1007 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
246 
Breithardt G, Cain ME, El-Sherif N, et al. (1991). Standards for Analysis of Ventricular Late 
Potentials Using High – Resolution or Signal – Averaged Electrocardiography. J Am 
Coll Cardiol, 17(5), pp. 999-1006 
Breithardt G,  Hackstein N, Borggreffe M, et al. (1990). Diagnostiv value of 
electrocardiographic variables to predict the presence of ventricular late potentials. 
J Am Coll Card, 15, pp. 152-8 
Breithardt G, Becker R, Seipel L, et al. (1981). Non-invasive detection of late potentials in 
man – a new marker for ventricular tachycardia. Eur Heart J, 2, pp. 1–11 
Brembilla-Perrot B, Suty-Selton C, Houriez P, et al. (2001). Value of non-invasive and 
invasive studies in patients with bundle branch block, syncope and history of 
myocardial infarction. Europace, 3, pp. 187-194 
Brembilla-Perrot B, Terrier de la Chaise A, Jacquemin L, et al. (1997). The signal-averaged 
electrocardiogram is of limited value in patients with bundle branch block and 
dilated cardiomyopathy in predicting inducible ventricular tachycardia or death. 
Am J Cardiol, 79(2), pp. 154-9  
Brune S, Gonska BD, Fleischmann C, et al. (1991). Prevalence of late ventricular potentials in 
hypertensive patients. J Cardiovasc Pharmacol, 17(Suppl 2), pp. S46-7   
Buckingham TA, Radin MM, Volgman AS, et al. (1993). Does atrial fibrillation cause false-
positive late potentials? Pacing Clin Electrophysiol, 16(12), pp. 2222-6 
Cain ME, Anderson JL, Arnsdorf MF, et al. (1996). Signal-Averaged Electrocardiography. 
ACC Expert Consensus Document. J Am Coll Card, 27(1), pp. 238-249 
Carjea MI. (2003). Prevalence of late ventricular potentials in patients with chronic 
obstructive lung disease. Pneumologia, 52(3-4), pp. 181-3 
Celli B, Decramer M, Leimer I, et al. (2010). Cardiovascular safety of tiotropium in patients 
with COPD. Chest, 137 (1), pp. 20-30 
Chew EW, Morton P, Murtagh JG, et al. (1990). Intravenous streptokinase for acute 
myocardial infarction reduces the occurrence of ventricular late potentials. BHJ, 64, 
pp. 5 
Christiansen EH, Frost L, Mlgaard H, et al. (1995). The signal-averaged ECG becomes late 
potential-positive at low noise levels in healthy subjects. Eur Heart J, 16, pp. 1731-5   
Chu CS,  Lee KT, Lee ST, et al. (2007). Effects of atorvastatin on ventricular late potentials 
and ventricular late potentials and repolarization dispersion in patients with 
hypercholesterolemia. Kaohsiung J Med Sci, 23, pp.217–24 
Clayton RN. (2003). Cardiovascular function in acromegaly. Endocrien Reviews, 24, pp. 272-
277 
Corrado D & Thiene G. (2006). Arrhythmogenic right ventricular cardiomyopathy/dysplasia: 
clinical impact of molecular genetic studies. Circulation, 113, pp. 1634-37  
Cripps TR, Counihan PJ, Frenneaux MP, et al. (1990). Signal-averaged electrocardiography 
in hypertrophic cardiomyopathy. J Am Coll Cardiol,15, pp. 956 
Fauchier JP, Cosnay P, Babuty D, et al. (1991). Etude du potential arrythmogene des 
myocardiopathies. Les myocardiopathies dilatees. Arch Mai Coeur, 84, pp. 95-103 
Daliento L, Caneve F, Turrini P, et al. (1995). Clinical significance of high-frequency, low 
amplitude electrocardiographic signals and QT dispersion in patients operated on 
for tetralogy of Fallot. Am J Cardiol., 76, pp. 408–411 
www.intechopen.com
 
Late Ventricular Potentials in Cardiac and Extracardiac Diseases 
 
247 
Day CP , James OF, Butler TJ, et al. (1993). QT prolongation and sudden cardiac death in 
patients with alcoholic liver disease. Lancet, 341, pp. 1423–8 
Dubrava J, Fekete J, Lehotska A. (2003). Relation of ventricular late potentials and 
intradialytic changes in serum electrolytes, ultrafiltration, left ventricular ejection 
fraction and left ventricular mass index in haemodialysis patients. Bratisl Lek Listy, 
104(12), pp. 388-392 
Ducceschi V, Sarubbi B, Giasi A, et al.(1996). Correlation between late potentials duration 
and QTc dispersion: Is there a causal relationship? Int J Cardiol, 53(3), pp. 285-290 
Ducceschi V, D’Andrea A, Sarubbi B, et al. (1998). Repolarization abnormalities in  patients 
with idiopatic ventricular tachycardias. Can J Cardiol., 14(12), pp. 1451-5 
Duflou J, Virmani R, Rabin L, et al. (1995). Sudden death as a result of heart disease in 
morbid obesity. Am Heart J, 130, pp. 306-13 
Engel G, Beckerman JG, Froelicher VF, et al. (2004). Electrocardiographic arrythmia risk 
testing. Curr Probl Cardiol, 29, pp. 357-432 
Engel TR, Pierce DL, Murphy SP. (1993). Variation in late potentials and the reproducibility 
of their measurement. Prog Cardiovasc Dis, 35, pp. 247-62 
Englund A, Rosenqvist M, Bergfeldt L. (1995). Use of signal-averaged electrocardiography 
for predicting inducible sustained monomorphic ventricular tachycardia in patients 
with bundle branch block with and without a history of syncope. Am Heart J, 130, 
pp. 481-8 
Faugere G, Savard P, Nadeau RA, et al. (1986). Characterization of the spatial distribution of 
late ventricular potentials by body surface mapping in patients with ventricular 
tachycardia. Circulation, 74, pp. 1323-1333 
Fetsch Th. (1999). Neue Methoden in der kardinalen Funktionsdiagnostik: Ventrikulare 
Spatpotentiale. Deutsches Ärzteblatt, 96(39), pp. A-2443/B-2105/C-1956 
Fitzgerald DM, Hawthorne HR, Crossley GH, et al. (1996). Effects of atrial fibrillation and 
atrial flutter on the signal-averaged electrocardiogram. Am J Cardiol, 77(2), pp. 205-9 
Folino AF, Bauce B, Frigo G, et al. (2006). Long-term follow-up of the signal-averaged ECG 
in arrhythmogenic right ventricular cardiomyopathy: correlation with arrhythmic 
events and echocardiographic findings. Europace, 8, pp. 423-29 
Frances RJ. (2010). Low noise level unmasks late potentials on signal-averaged 
electrocardiography. Exp Clin Cardiol, 15(3), pp. e61-e64 
Franchi F, Michelucci A, Padeletti L, et al. (1992). Arrhythmogenesis in left ventricular 
hypertrophy in mild to moderate essential hypertension. G Ital Cardiol, 23, pp. 905-
18 
Freedman RA & Steinberg JS. (1991). Selective prolongation of QRS late potentials by 
sodium channel blocking antiarrhythmic drugs: relation to slowing of ventricular 
tachycardia. J Am Coll Cardiol, 17, pp. 1017-25 
Galinier M, Balanescu S, Fourcade J, et al. (1997). Prognostic value of arrhythmogenic 
markers in systemic hypertension. Eur Heart J, 18, pp. 1484-1491 
Galinier M, Albenque JP, Afchar N, et al. (1996). Prognostic value of late potentials in 
patients with congestive heart failure. Eur Heart J, 17, pp. 264-271 
Galinier M, Doazan JP, Albemque JP, et al. (1992). Cardiopathie hypertensive et potentiels 
tardifs ventriculaires. Arch Mal Coeur Vaiss, 85, pp. 1095-8 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
248 
Gang ES, Peter T, Rosenthal ME, et al. (1986). Detection of late potentials on the surface 
electrocardiogram in unexplained syncope. Am J Cardiol, 58(10), pp. 1014-20 
Gatzoulis KA, Biblo LA, Waldo AL, et al. (1993). Atrial flutter causes pseudo late potentials 
on signal-averaged electrocardiogram. Am J Cardiol, 71, pp. 251 
Genovesi S, Dossi C, Vigano MR, et al. (2008). Electrolyte concentration during 
haemodialysis and QT interval prolongation in uraemic patients. Europace, 10, pp. 
771–777 
Gimaev RKh, Ruzov VI, Razin VA, et al. (2009). Effect of lipid metabolism disturbances on 
electrophysiologic heart remodeling in patients with hypertensive disease. Klin 
Med, 87(11), pp. 30-3 
Giroud D, Zimmermann M, Adamec R, et al. (1994). Ventricular late potentials and 
spontaneous ventricular arrhythmias after surgical repair of tetralogy of Fallot. Do 
they have prognostic value? Br Heart J, 72, pp. 580–583 
Girgis I, Contreras G, Chakko S Perez G, et al. (1999). Effect of hemodialysis on the signal-
averaged electrocardiogram. Am J Kidney Dis, 34, pp. 1105-1113 
Goldberger JJ, Cain ME, Hohnloser SH, et al. (2008). American Heart Association/American 
College of Cardiology Stratification Techniques for Identifying Patients at Risk for 
Sudden Cardiac Foundation/Heart Rhythm Society Scientific Statement on 
Noninvasive Risk and Council on Epidemiology and Prevention on Clinical 
Cardiology Committee on Electrocardiography and Arrhythmias. J Am Coll Cardiol, 
52, pp. 1179-1199 
 Goldberger JJ, Ahmed MW, Parker MA et al. (1994). Assessment of effects of autonomic 
stimulation and blockade on the signal-averaged electrocardiogram. Circulation, 89, 
pp. 1656–64 
Gomes JA, Cain ME, Buxton AE, et al. (2001). Prediction of long-term outcomes by signal-
averaged electrocardiography in patients with unsustained ventricular tachycardia, 
coronary artery disease, and left ventricular dysfunction. Circulation, 104, pp. 436 
Gomez-Leon Manduiano A & Amezcua-Guerra LM. (2008). Cardiovascular manifestations 
of systemic lupus erythematosus. Arch Cardiol Mex, 78(4), pp. 421-30 
Gottfridsson C, Karlsson T, Edvardsson N. (2011). The signal-averaged electrocardiogram 
before and after electrical cardioversion of persistent atrial fibrillation – 
implications of the sudden change in rhythm. J Electrocardiol, 44, pp. 2420 
Gussack I & Antzelevitch C. (2008). Electrical Diseases of the Heart. Genetics, Mechanisms, 
Treatment, Prevention. Springer, London 
Halimi F, Le Heuzey JY, Lavergne T, et al. (1994). Limitations of ventricular late potentials in 
atrial fibrillation. Arch Mal Coeur Vaiss, 87(9), pp. 1201-6 
Hancock EW, Deal BJ, Mirvis DM, et al. (2009). AHA/ACCF/HRS recommendations for the 
standardization and interpretation of the electrocardiogram: part V: 
electrocardiogram changes associated with cardiac chamber hypertrophy: a 
scientific statement from the American Heart Association Electrocardiography and 
Arrhythmias Committee, Council on Clinical Cardiology; the American College of 
Cardiology Foundation; and the Heart Rhythm Society. J Am Coll Cardiol, 53, pp. 
992–1002 
Hayward RP, Emanuel RW, Nabarro JDN. (1987). Acromegalic heart disease: influence of 
treatment of acromegaly on the heart. QJ Med, 62, pp. 41-58 
www.intechopen.com
 
Late Ventricular Potentials in Cardiac and Extracardiac Diseases 
 
249 
Herrmann BL, Bruch C, Saller B, et al. (2001). Occurence of ventricular late potentials in 
patients with active acromegaly. Clinical Endocrinology, 55, pp.  201-207 
Herzog CA, Mangrum JM, Passman R. (2008). Sudden cardiac death and dialysis patients. 
Semin Dial, 21(4), pp. 300-7  
Ho DS, Daly M, Richards DA, et al. (1996). Behavior of late potentials on the body surface 
during programmed ventricular stimulation. J Am Coll Cardiol, 28(5), pp. 1283-91 
Ho DS, Denniss RA, Uther JB, et al. (1993). Signal-averaged electrocardiogram. Improved 
identification of patients with ventricular tachycardia using a 28-lead optimal 
array. Circulation, 87(3), pp. 857-865 
Hohnloser SH, Franck P, Klingenheben T, et al. (1994). Open infarct artery, late potentials, 
and other prognostic factors in patients after acute myocardial infarction in the 
thrombolytic era. Circulation, 90, pp. 1747 
Huebner T, Goernig M, Schuepbach M, et al. (2010) Electrocardiologic and related methods 
of non-invasive detection and risk stratification in myocardial ischemia: state of the 
art and perspectives. German Medical Science, 8, Doc 27 
Ichikawa H, Nagake Y, Makino H. (1997). Signal averaged electrocardiography in patients 
on hemodyalisis. J Med, 28, pp. 229-243 
Ikeda T, Saito H, Tanno K, et al. (2002). T-wave alternans as a predictor for sudden cardiac 
death after myocardial infarction. Am J Cardiol, 89, pp. 79 
Ikeda T, Sakurada H, Sakabe K, et al. (2001). Assessment of noninvasive markers in 
identifying patients at risk in the Brugada syndrome: insight into risk stratification. 
J Am Coll Cardiol, 37, pp. 1628 
Iltumur K, Karabulut A, Temamogullari AV, et al. (2001). The relation between infarction 
localization and late potentials. Anadolu Kardiyol Derg, 1(2), pp. 76-79 
Isma' eel H, Shamseddeen W, Taher A, et al. (2007).Ventricular late potentials among 
thalassemia patients. Int J Cardiol, 132(3), pp. 453-5 
Jain P & Avasthi R. (2004). Corelation beteen dispersion of repolarization and ventricular 
ectopic beat frequency in patients with acute myocardial infarction: a marker for 
risk of arrhythmogenesis. Int J Cardiol, 93, pp. 69-73 
Janousek J, Paul T, Bartakova H. (1995). Role of late potentials in identifying patients at risk 
for ventricular tachycardia after surgical correction of congenital heart disease. Am 
J Cardiol, 75, pp. 146–150 
Junker A, Ahlquist P, Thayssen P, et al. (1995).Ventricular late potentials and left ventricular 
function after early enalapril treatment in acute myocardial infarction. Am J Cardiol, 
76, pp. 1300 
Kaftan AH & Kaftan O. (2000). QT intervals and heart rate variability in hypertensive 
patients. Jpn Heart J, 41(2), pp. 173-82 
Kahaly G, Olshausen KV, Mohr-Kahaly S, et al. (1992). Arrhythmia profile in acromegaly. 
Eur Heart J, 13, pp. 51-56 
Kamath GS, Zareba W, Delaney J, et al. (2011). Value of the signal-averaged 
electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. 
Heart Rhythm, 8(2), pp. 256-62 
Kannel WB & Abbot RD. (1986). A prognostic comparison of asymptomatic left ventricular 
hypertrophy and unrecognized myocardial infarction: the Framingham Study. Am 
Heart J, 111(2), pp. 391-7 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
250 
Karayaylali I, San M, Kudaiberdieva G, et al. (2003). Heart rate variability, left ventricular 
functions, and cardiac autonomic neuropathy in patients undergoing chronic 
hemodialysis. Ren Fail, 25(5), pp. 845-53 
Kayikcioglu M, Can L, Evrengul H, et al. (2003). The effect of statin therapy on ventricular 
late potentials in acute myocardial infarction. Int J Cardiol, 90, pp. 63 
Kitamura H, Yoshida A, Ohnishi Y, et al. (2003). Correlation of connexin 43 expression and 
late ventricular potentials in nonischemic dilated cardiomyopathy. Circ J, 67, pp. 
1017-1021  
Kondo N, Ikeda T, Kawase A, et al. (2001). Clinical usefulnes of the combination of T-wave 
alternans and late potentials for identifying high-risk patients with moderately or 
severly impaired left ventricular function. Jpn Circ J, 65, pp. 649-653 
Konta T, Ikeda K, Kubota I, et al. (1988). Relationship between late potentials and left 
ventricular function in patients with coronary artery disease. Jpn Circ J, 52(2), pp. 
105-110  
Koskinen P & Kupari M. (1993). Signal-Averaged Electrocardiography in Asymptomatic 
Alcoholics. Am J Cardiol, 17, pp. 254-255 
Kovesdy CP, Regidor DL, Mehrotra R, et al. (2007). Serum and dialysate potassium 
concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol, 2, pp. 
999-1007 
Kowalewski MA, Urban M, Florys B, et al. (2002). Late potentials: Are they related to 
cardiovascular complications in children with type 1 diabetes? Journal of Diabetes 
and its complications, 16(4), pp. 263-270 
Kuchar DL, Thorburn CW, Sammel NL. (1986). Late potentials detected after myocardial 
infarction: natural history and prognostic significance. Circulation, 74, pp. 1280 
Kudaiberdieva G, Gorenek B, Goktekin O, et al. (2003). Combination of QT variability and 
signal-averaged electrocardiography in association with ventricular tachycardia in 
postinfarction patients. J Electrocardiol, 36(1), pp. 17-24 
Kutsuzawa D, Arimoto T, Watanabe T, et al. (2011). Persistent abnormal value of late 
potential in Brugada syndrome associated with hypokalemia. Ann Noninvasive 
Electrocardiol, 16(1), pp. 104-6 
Lalani AP, Kanna B, John J, et al. (2000). Abnormal Signal-Averaged Electrocardiogram 
(SAECG) in Obesity. Obesity Research, 8(1), pp. 20-28 
Lander P, Berbari EJ, Rajagopalan CV, et al. (1993). Critical analysis of the Signal-averaged 
electrocardiogram. Improved identification of late potentials. Circulation, 87, pp. 
105 
La Vecchia L, Ometto R, Bedogni F, et al. (1998). Ventricular late potentials, interstitial 
fibrosis, and right ventricular function in patients with ventricular tachycardia and 
normal left ventricular function. Am J Cardiol, 15, pp. 790– 792 
Lazzerini PE, Capecchi PL, Laghi-Pasini F. (2010). Anti-Ro/SSA antibodies and cardiac 
arrhythmias in the adult: facts and hypotheses. Scand J Immunol, 72(3), pp. 213-22 
Lazzerini PE, Capecchi PL, Guideri F, et al. (2007). Comparison of frequency of complex 
ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and 
connective tissue diseases. Am J Cardiol, 100(6), pp. 1029-34 
Lazzerini PE, Capecchi PL, Guideri F, et al. (2006). Connective tissue diseases and cardiac 
rhythm disorders: an overview. Autoimmun Rev, 5(5), pp. 306-13 
www.intechopen.com
 
Late Ventricular Potentials in Cardiac and Extracardiac Diseases 
 
251 
Lekawanvijit S & Chattipakorn N. (2009). Iron overload thalassemic cardiomyopathy: Iron 
status assessment and mechanisms of mechanical and electrical disturbance due to 
iron toxicity. Can J Cardiol, 25(4), pp. 213-218  
Levy D, Garrison RJ, Savage DD, et al. (1990). Prognostic implications of 
echocardiographically determined left ventricular mass in the Framingham Heart 
Study. N Engl J Med, 322, pp. 1561-6 
Liew R. (2011). Electrocardiogram-based predictors of sudden cardiac death in patients with 
coronary artery disease. Clin Cardiol, 34 (8), pp. 466-473 
Linnenbank AC, van Dessel PFHM, Potse M, et al. (2001). Localization of late potentials 
using body surface mapping. Biomed Techn, pp. 204-206 
Liu YB, Wu CC, Lu LS, et al. (2003). Sympathetic Nerve Sprouting, electrical remodeling, 
and increased vulnerability to ventricular fibrillation in hypercholesterolemic 
rabbits. Circ Res, 92, pp. 1145-1152 
Liu YB, Lee YT, Pak HN, et al. (2009). Effects of simvastatin on cardiac neural and 
electrophysiologic remodeling in rabbits with hypercholesterolemia. Heart Rhythm, 
6(1), pp. 69–75 
Lorsheyd A & de Lange DW. (2005). PR and QTc interval prolongation on the 
electrocardiogram after binge drinking in healthy individuals. Neth J Med, 2(63), pp. 
59-63  
Luca C. (1979). Electrophysiological properties of right heart and atrioventricular 
conducting system in patients with alcoholic cardiomyopathy. Br Heart J, 42, pp. 
274-281 
Malik M, Kulakowski P, Odemuyiwa O, et al. (1992). Effect of thrombolytic therapy on the 
predictive value of signal-averaged electrocardiography after acute myocardial 
infarction. Am J Cardiol, 70, pp. 21 
Mancini DM, Wong KL, Simson MB. (1993). Prognostic value of an abnormal signal-
averaged electrocardiogram in patients with nonischemic congestive 
cardiomyopathy. Circulation, 84, pp. 1083 
Manolis AS, Chiladakis JA, Malakos JS, et al. (1997). Abnormal signal-averaged 
electrocardiograms in patients with incomplete right bundle-branch block. Clin 
Cardiol, 20(1), pp. 17-22  
Mather AN, Fairbairn TA, Ball SG, et al. (2011). Reperfusion haemorrhage as determined by 
cardiovascular MRI is a predictor of adverse left ventricular remodelling and 
markers of late arrhythmic risk. Heart, 97, pp. 453-9 
Meinertz T, Treese N, Kaspar W, et al. (1985). Determinant of prognosis in idiopathic dilated 
cardiomyopathy as determined by programmed electrical stimulation. Am J Cardiol, 
56, pp. 337-41 
Mehta D & Camm AJ. (1989). Signal-averaged electrocardiography and the significance of 
late potentials in patients with „idiopathic” ventricular tachycardia: a review. 
Clicical Cardiology, 12(6), pp. 307-12 
Meregalli PG, Wilde AA, Tan HL. (2005). Pathophysiological mechanisms of Brugada 
syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc 
Res, 67, pp. 367-378  
Middlekauff H, Stevenson W, Woo M, et al. (1990). Comparison of frequency of late 
potentials in idiopathic dilated cardiomyopathy and ischemic cardiomyopathy 
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
252 
with advanced heart failure and their usefulness in predicting sudden death. Am J 
Cardiol, 66, pp. 1113-17 
Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, et al. (2000). The QT interval dispersion 
and ventricular late potential in obese women. Pol Merkur Lekarski, 8(44), pp. 84-6 
Morales MA, Gremigini C, Dattalo P, et al. (1998). Signal-averaged ECG abnormalities in 
haemodyalisis patients. Role of dialysis. Nephrol Dial Transplant, 13, pp. 668-673 
Morita H, Kusano KF, Miura D, et al. (2008). Fragmented QRS as a marker of conduction 
abnormality and a predictor of prognosis of Brugada syndrome. Circulation, 118, 
pp. 1697-1704 
Morita H, Zipes DP, Morita ST. (2007). Differences in the arrhythmogenicity between the 
canine right ventricular outflow tract and anteroinferior right ventricle in a model 
of Brugada syndrome. Heart Rhythm, 4, pp. 66-74 
Moushmoush B & Abi-Mansour P. (1991). Alcohol and the heart. The long-term effects of 
alcohol on the cardiovascular system. Arch Intern Med, 151, pp. 36-42 
Mozos I, Hancu M, Serban C, et al. (2011). Late ventricular potentials can be predicted from 
twelve-lead ECG in post-infarction heart failure. International Journal of Collaborative 
Research on Internal Medicine & Public Health, 3, pp. 53-63 
Mozos I & Hancu M. (2010). High serum cholesterol and electrical instability in patients 
with an old myocardial infarction. Atherosclerosis Supplements, 11(2), pp. 109-222 
Mozos I, Hancu M, Costea C, et al. (2009). Left ventricular hypertrophy and ventricular 
arrhythmia risk in post-infarction heart failure, In: Proceedings of the IVth Congress of 
the Academy of Romanian Scientists „Quality of Life”, October 15-17, 2009, Timisoara, 
Candea V, Andea P, Popoviciu MO, Kilyeni St, pp. 335- 42, Orizonturi Universitare 
Publishing House, Timisoara, Romania 
Mozos I, Hancu M, Cristescu A. (2008). The Relation between Late Ventricular Potentials 
and Isointegral QRST Body Surface Maps in Chronic Myocardial Infarction 
Patients, In: XXVIII European Section Meeting of the International Society for Heart 
Research. Athens (Greece), May 28-31, 2008, pp. 47-50, Medimond International 
Proceedings. Monduzzi Editore, Bologna, Italy 
Mozos I. (2007). Aspecte ale vulnerabilitatii la aritmii ventriculare in infarctul miocardic cronic, 
Mirton Publishing House, Timisoara, Romania  
Mozos I, Hancu M, Chiulan C, et al. (2007). Aspects of Electrical Instability in Obese Chronic 
Myocardial Infarction Patients, In: Joint Meeting of the Slovak Physiological Society, the 
Physiological Society and the Federation of European Physiological Societies. Bratislava 
(Slovak Republic), September 11-14, 2007,  Strbak V, pp. 95-98, Medimond 
International Proceedings. Monduzzi Editore, Bologna, Italy 
Mozos I. (2006). The relation between late ventricular potentials and electrocardiographic 
dispersion of ventricular activity in myocardial infarction patients. Timisoara 
Medical Journal, 2-3 (56), pp. 157-162 
Muntean D, Varro A, Jost N, et al. (2009). Translational research in cardiovascular disease: a 
cross-border approach. Victor Babes Publishing House, Timisoara, Romania 
Nakai K, Ito C, Koh E, et al. (1988). Relationship between the occurence of late potential on 
the body surface ECG and cardiac performance in myocardial infarction. J Cardiol, 
18(1), pp. 207-215 
www.intechopen.com
 
Late Ventricular Potentials in Cardiac and Extracardiac Diseases 
 
253 
Nashoni E, Strasberg B, Imbar S, et al. (2010). Late potentials in the signal-averaged 
electrocardiogram in schizophrenia patients maintained on antipsychotic agents. A 
preliminary naturalistic study. European Neuropsychopharmacology, 20, pp. 146-152 
Nava A, Folino AF, Bauce B, et al. (2000). Signal-averaged electrocardiogram in patients 
with arrhythmogenic right ventricular cardiomyopathy and ventricular 
arrhythmias. Eur Heart J, 21, pp. 58-65 
Ohnischi Y, Inoue T, Fukuzaki H. (1990).Value of the signal averaged electrocardiogram  as 
a predictor of sudden death in myocardial infarction and dilated cardiomyopathy. 
Jpn Circ J, 54, pp. 127-36 
Oikarinen L, Nieminen MS, Viitasalo M, et al. ( 2004). QRS Duration and QT Interval Predict 
Mortality in Hypertensive Patients with Left Ventricular Hypertrophy. The 
Losartan Intervention for Endpoint Reduction in Hypertension Study. 
Hypertension,43, pp. 1029-1034 
Olinic N. & Zdrenghea D. (1998). Cardiopatia ischemica. Clusium Publishing House, Cluj-
Napoca, Romania 
Osadchii O. (2010). Mechanisms of hypokalemia-induced ventricular arrhythmogenicity. 
Fundamental and Clinical Pharmacology, 24(5), pp. 547-59 
Pacher P, Ungvari Z, Nanasi PP, et al. (1999). Electrophysiological changes in rat ventricular 
and atrial myocardium at different stages of experimental diabetes. Acta Physiol 
Scand, 166(1), pp. 7-13 
Palatini P, Maraglino G, Accurso V, et al. (1995). Impaired left ventricular filling in 
hypertensive left ventricular hypertrophy as a marker of the presence of an 
arrhythmogenic substrate. Br Heart J, 73, pp. 258-62 
Panagides D, Amabile G, Deharo JC, et al. (1990). Etude des potentiels tardifs chez 
l'hypertendu. Arch Mal Coeur Vaiss, 83, pp. 1165-8 
Paradiso M, Di Franco M, Musca A, et al. (2002). Ventricular late potentials in systemic 
sclerosis: relationship with skin involvement. J Rheumatol, 29(7), pp. 1388-92 
Paradiso M, Gabrielli F, Masala C, et al. (2001). Evaluation of myocardial involvement in 
systemic lupus erythematosus by signal-averaged electrocardiography and 
echocardiography. Acta Cardiol, 56(6), pp. 381-6  
Paradiso M, Gabrielli F, Coppotelli L, et al. (1996). Signal-averaged electrocardiography and 
echocardiography in the evaluation of myocardial involvement in progressive 
systemic sclerosis. Int J Cardiol, 53(2), pp. 171-7 
Peters NS, Coromilas J, Severs NJ, et al. (1997). Disturbed connexin43 gap junction 
distribution correlates with the location of reentrant circuits in the epicardial border 
zone of healing canine infarcts that cause ventricular tachycardia. Circulation, 95, 
pp. 988 – 996 
Pignone A, Matucci-Cerinic M, Becucci A, et al. (1994). Patterns of ventricular late potentials 
in systemic sclerosis: a noninvasive method in the study of cardiac involvement. 
Ann Ital Med, 9(3), pp. 141-5   
Pochmalicki G, Genest M, Jibril H. (1997). Late ventricular potentials and heavy drinking. 
Heart, 78, pp. 163-165  
Pollak SJ, Kertes PJ, Bredlau CE, et al. (1985). Influence of left ventricular function on signal 
averaged late potentials in patients with coronary artery disease with and without 
ventricular tachycardia. Am Heart J, 110(4), pp. 747-52  
www.intechopen.com
 
Cardiac Arrhythmias – New Considerations 
 
254 
Priori SG, Aliot E, Blomstrom-Lundqvist C, et al. Task Force on Sudden Cardiac Death of the 
European Society of Cardiology. (2001). Task Force Report. Eur Heart J, 22(16), pp. 
1374-1450 
Prisant LM, Wylds AC, Carr AA, et al. (1993). Assessment of late potentials in patients with 
essential hypertension by the signal-averaged electrocardiogram with five year 
follow-up. J Hypertens, 7, pp. 497-503 
Rizzo V, Di Maio F, Villatico Campbell S, et al. (2000). Left ventricular function, cardiac 
dysrhythmias, atrial activation, and volumes in nondipper hypertensive 
individuals with left ventricular hypertrophy. Am Heart J, 139, pp. 529-36 
Rodrigues EA, Caruana MP, Lahiri A, et al. (1989). Subclinical cardiac dysfunction in 
acromegaly: evidence for a specific disease of heart muscle. Br Heart J, 62, pp. 185-
194 
Roithinger FX, Punzengruber C, Rossoll M, et al. (1992). Ventricularlate potentials in 
haemodyalisis patients and the risk of sudden death. Nephrol Dial Transplant, 7, pp. 
1013-1018 
Russo V, Rago A, Pannone B, et al. (2011). Dispersion of repolarization and beta-thalassemia 
major: the prognostic role of QT and JT dispersion for identifying the high-risk 
patients for sudden death. Eur J Haematol, 86(4), pp.324-31 
Sakhuja R, Shah AJ, Hiremath S, et al. (2009). End-stage renal disease and sudden cardiac 
death. Cardiac Electrophysiology Clinics, 1(1), pp. 61-77 
Santangeli P, Pieroni M, Dello Russo A, et al. (2010). Noninvasive diagnosis of 
electroanatomic abnormalities in arrhythmogenic right ventricular 
cardiomyopathy. Circulation: Arrhythmia and Electrophysiology, 3, pp. 632-8 
Santangeli P, Infusino F, Sgueglia GA, et al. (2008). Ventricular late potentials: a critical 
overview and current applications. J Electrocardiol, 41, pp. 318-324 
Santarelli P, Lanza GA, Biscione F, et al. (1993). Effects of thrombolysis and atenolol or 
metoprolol on the signal-averaged electrocardiogram after acute myocardial 
infarction. Am J Cardiol, 72, pp. 521 
Savard P, Rouleau JL, Ferguson J, et al. (1997). Risk Stratification After Myocardial Infarction 
Using Signal-Averaged Electrocardiografic Criteria Adjusted for Sex, Age, and 
Myocardial Infarction Location. Circulation, 96, pp. 202-213 
Schunkert H. (2002). Obesity and target organ damage: the heart. International Journal of 
Obesity, 26 (Suppl 4), pp. S15 – S20 
Seferovic PM, Ristic AD, Maksimovic R, et al. (2006). Cardiac arrhythmias and conduction 
disturbances in autoimmune rheumatic diseases. Rheumatology, 45, pp. iv39-iv42 
Silverman ME, Pressel MD, Bracken JC, et al. (1995). Prognostic value of the signal-averaged 
electrocardiogram and a prolonged QRS in ischemic and nonischemic 
cardiomyopathy. Am J Cardiol, 75, pp. 460-64 
Simson MB. (1981). Use of signals in the terminal QRS complex to identify patients with 
ventricular tachycardia after myocardial infarction. Circulation, 64, pp. 235–42 
Stanescu C & Dan GA. (1992). Myocardial involvement in systemic lupus erythematosus 
and systemic sclerosis – pulsed Doppler echocardiographic evaluation of left 
ventricular diastolic function. Rom J Intern Med, 30(4), pp. 243-8 
Steinberg J & Berbari EJ. (1996). The signal-averaged electrocardiogram: update on clinical 
applications. J Cardiovasc Electrophysiol, 7, pp. 972 
www.intechopen.com
 
Late Ventricular Potentials in Cardiac and Extracardiac Diseases 
 
255 
Steinberg JS & Bigger JT. (1989). Importance of the endpoint of noise reduction in analysis of 
the signal-averaged electrocardiogram. Am J Cardiol, 63, pp. 556-60 
Steinbigler P, Haberl R, Jeleazcov C, et al. (1999). Functional changes of ventricular late 
potentials by provocation with increase of heart rate. Europace, 1, pp. 103-112 
Strohmer B, Schernthaner C, Iglseder B, et al. (2007). Gender-specific effect of metabolic 
syndrome on rate adjusted QT interval in middle-aged participants of an 
atherosclerosis prevention program. Wien Klin Wochenschr, 119(17-18), pp. 544-52 
Sanjuan R, Nunez J, Blasco ML, et al. (2011). Prognostic implications of stress hyperglycemia 
in acute ST elevation myocardial infarction. Prospective observational study. Rev 
Esp Cardiol, 64(3), pp. 201-7 
Teixeira RA, Ferreira Borba E, Bonfa E, et al. (2010). Arrhythmias in systemic lupus 
erythematosus. Bras J Rheumatol, 50(1), 81-9 
Turrini P, Angelini A, Thiene G, et al. (1999). Late potentials and ventricular arrhythmias in 
arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol, 15, pp. 1214– 1219 
Vardas PE, Simandirakis EN, Parthenakis FI, et al. (1994). Study of late potentials and 
ventricular arrhythmias in hypertensive patients with normal electrocardiograms. 
Pacing Clin Electrophysiol, 17, pp. 577-84 
Vester EG, Kuhls S, Ochiulet-Vester J, et al. (1992). Electrophysiological and therapeutic 
implications of cardiac arrhythmias in hypertension. Eur Heart J, 13(Suppl D), pp. 
70-81 
Vreede-Swagemakers JJ, Gorgels AP, Weijenberg MP, et al. (1999). Risk indicators for out-of-
hospital cardiac arrest in patients with coronary artery disease. J Clin Epidemiol, 52, 
pp. 601–7 
Wever EFD & Robles de Medina EO. (2004). Sudden death in patients without structural 
heart disease. J Am Coll Cardiol, 43(7), pp. 1137-1144 
Wilson JR, Schwartz JS, St John Sutton M, et al. (1983). Prognosis in severe heart failure: 
Relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll 
Cardiol, 3, pp. 403-10 
Wranicz JK, Cygankiewicz I, Zielinska M, et al. (2001). Non-invasive cardiac evaluation in 
patients with systemic lupus erythematosus. J Med, 32(3-4), pp. 195-206 
Yang W, Horan LG, Flowers NC. (1990). An Analysis of Beat-By-Beat Recording of Late 
Potentials and His-Purkinje Signals in a Hospital Environment. J Cardiovasc 
Electrophysiol, 1, pp. 486-495 
Yildirir A, Batur MK, Oto A. (2002). Hypertension and arrhythmia: blood pressure control 
and beyond. Europace, 4(2), pp. 175-82 
Yodogawa K, Seino Y, Ohara T, et al. (2011). Effect of corticosteroid therapy on ventricular 
arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol, 
16(2), pp. 140-7  
Zaman AG, Morris JL, Smyllie JH, et al. (1993). Late potentials and ventricular enlargement 
after myocardial infarction. A new role for high-resolution electrocardiography? 
Circulation, 88(3), pp. 905-914 
Zhao J, Yang Y, Pei W, et al. (2008). Effect of statin therapy on reperfusion arrhythmia in 




Cardiac Arrhythmias – New Considerations 
 
256 
Zimmermann M, Adamec R, de Lorgeril M, et al. (1983). Detection non invasve des 
potentiels tardifs de l'activation ventriculaire: identification et signification dans la 
maladie coronarienne. Schwei Med Wschr, 113, pp. 1678-1680 
Zimmermann M, Friedli B, Adamec R, et al. (1991).Ventricular late potentials and induced 
ventricular arrhythmias after surgical repair of tetralogy of Fallot. Am J Cardiol, 67, 
pp. 873–878 
Zipes DP, Camm AJ, Borggrefe M, et al. (2006). ACC/AHA/ESC 2006 Guidelines for 
Management of patients with Ventricular Arrhythmias and the Prevention of 
Sudden Cardiac Death. J Am Coll Cardiol, 48(5), pp. 247-346 
www.intechopen.com
Cardiac Arrhythmias - New Considerations
Edited by Prof. Francisco R. Breijo-Marquez
ISBN 978-953-51-0126-0
Hard cover, 534 pages
Publisher InTech
Published online 29, February, 2012
Published in print edition February, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The most intimate mechanisms of cardiac arrhythmias are still quite unknown to scientists. Genetic studies on
ionic alterations, the electrocardiographic features of cardiac rhythm and an arsenal of diagnostic tests have
done more in the last five years than in all the history of cardiology. Similarly, therapy to prevent or cure such
diseases is growing rapidly day by day. In this book the reader will be able to see with brighter light some of
these intimate mechanisms of production, as well as cutting-edge therapies to date. Genetic studies,
electrophysiological and electrocardiographyc features, ion channel alterations, heart diseases still unknown ,
and even the relationship between the psychic sphere and the heart have been exposed in this book. It
deserves to be read!
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Ioana Mozoş, Corina Şerban and Rodica Mihăescu (2012). Late Ventricular Potentials in Cardiac and
Extracardiac Diseases, Cardiac Arrhythmias - New Considerations, Prof. Francisco R. Breijo-Marquez (Ed.),
ISBN: 978-953-51-0126-0, InTech, Available from: http://www.intechopen.com/books/cardiac-arrhythmias-
new-considerations/late-ventricular-potentials-in-cardiac-and-extracardiac-diseases
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
